| Model Number |
407137 |
| Medical Device Problem Code |
Premature Elective Replacement Indicator (1483)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
04/22/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
This device shows eri with unexpected battery behavior.Device remains implanted.No adverse patient events were reported.Should additional information become available, this file will be updated.
|
| |
|
Additional Manufacturer Narrative
|
|
The device was explanted (b)(6) 2025.The device was not returned for analysis.The analysis is therefore only based on the returned device data as well as the inspection of the quality documents associated with the manufacture of this particular device.The manufacturing process for this device was reviewed.All production steps had been performed accordingly.There was no sign of any inconsistency during the manufacturing.The final acceptance test proved the device functions to be as specified.In a next step, the returned device data was inspected.During the inspection the clinical observation could be confirmed.Analysis revealed an unexpected battery behavior, which led to the clinical observation.Based on the data available for analysis the root cause for that behavior was not determinable and can only be clarified by an analysis of the device itself.However, it cannot be excluded that this occurrence resulted from a defective component, which may compromise the ability of the device to deliver therapy.Biotronik has informed the health care professional about this analysis result, who decides, based on the patients individual circumstances and medical judgment, if the device will be exchanged.Should further relevant information or the device itself become available, this investigation will be updated and you will be informed accordingly.
|
| |
|
Additional Manufacturer Narrative
|
|
The device was explanted (b)(6) 2025.The device was received and analyzed.Prior to the analysis of the device, the manufacturing process for this pacemaker was reviewed and all production steps were performed accordingly.There was no sign of any inconsistency during the manufacturing process.Particularly the final acceptance test proved the device functions to be as specified.Upon receipt, the device was interrogated showing the eri battery status, which was triggered on (b)(6) 2025.The ability of the device to deliver therapies was tested.The anti-bradycardia pacing pulses in eri mode proved to be normal and in amplitude and frequency as programmed.There was no indication of a malfunction.In a next step, the pacemaker was opened and subjected to further analysis.The visual inspection of the inner assembly showed no anomalies.The current consumption of the electrical module was directly measured and proved to be normal and as expected.There was no indication of a malfunction of the electrical module.The battery was sent to the manufacturer for further analysis.The manufacturing records of the battery were inspected, documenting that the battery parameters were within specification during the battery manufacturing.No anomalies were documented during the production process associated with this battery.The visual inspection of the battery did not reveal any external signs of damage.Further extensive analysis of the battery, including destructive analysis, identified an elevated internal battery impedance, leading to the activation of the eri battery status.In conclusion, the therapeutic functionality of the device was tested and proved to be fully functional.Further investigations revealed an elevated battery impedance as the root cause of the eri activation.
|
| |
|
Search Alerts/Recalls
|